AMW GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AMW GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11177
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AMW GmbH (AMW) is a pharmaceutical company that develops and manufactures drug delivery systems for treatment in the areas of oncology, neurology, dermatology and pain. The company designs and develops novel transdermal drug delivery systems, microchip controlled patches and biodegradable subcutaneous implants for the treatment of various hormone responding tumors, chronic pain and psychiatric diseases. Its products for licensing include Goserelin implant, Leuprorelin implant, Buprenorphin patch and Rivastigmin patch. AMW offers development partnerships with open and transparent collaboration with licensees for exclusive products. The company develops patented technologies for the active control of drug releasing pharmaceuticals. AMW is headquartered in Warngau, Germany.

AMW GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AMW GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AMW GmbH, Medical Devices Deals, 2012 to YTD 2018 9
AMW GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AMW GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
AMW Receives USD29.6 Million of Financing 11
AMW Raises USD6.4 Million in Venture Financing 12
AMW Raises USD9 Million in Venture Financing 13
AMW Raises Funds in Venture Financing 15
AMW Raises Funds in Third Round of Financing 16
Private Equity 17
AMW to Sell Shares to Hybio Pharma and YF Capital Led Consortium 17
AMW GmbH – Key Competitors 19
AMW GmbH – Key Employees 20
AMW GmbH – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Government and Public Interest 22
Dec 21, 2017: Investment Plan for Europe: EIB grants financing to pharmaceutical company AMW 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
AMW GmbH, Pharmaceuticals & Healthcare, Key Facts 2
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AMW GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AMW GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
AMW GmbH, Medical Devices Deals, 2012 to YTD 2018 9
AMW GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AMW Receives USD29.6 Million of Financing 11
AMW Raises USD6.4 Million in Venture Financing 12
AMW Raises USD9 Million in Venture Financing 13
AMW Raises Funds in Venture Financing 15
AMW Raises Funds in Third Round of Financing 16
AMW to Sell Shares to Hybio Pharma and YF Capital Led Consortium 17
AMW GmbH, Key Competitors 19
AMW GmbH, Key Employees 20

List of Figures
AMW GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AMW GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AMW GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[AMW GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Delta Air Lines, Inc.:企業のM&A・事業提携・投資動向
    Delta Air Lines, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Delta Air Lines, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Workday, Inc.:企業のM&A・事業提携・投資動向
    Workday, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Workday, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Edison SpA:発電所・企業SWOT分析
    Edison SpA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executi …
  • Vinnolit GmbH & Co KG:企業の戦略的SWOT分析
    Vinnolit GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • P. H. Glatfelter Co (GLT):企業の財務・戦略的SWOT分析
    P. H. Glatfelter Co (GLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Florida Keys Electric Cooperative Association, Inc.:企業の戦略的SWOT分析
    Florida Keys Electric Cooperative Association, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key compe …
  • East Central Energy:企業の発電所・SWOT分析2018
    East Central Energy - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Qualcomm Incorporated (QCOM):医療機器:M&Aディール及び事業提携情報
    Summary Qualcomm Incorporated (Qualcomm) is a technology and communication company. The company designs and manufactures digital wireless telecommunications products and services. Qualcomm offers integrated circuits and system software for wireless mobile devices. The major technologies such as code …
  • Whitehead Institute for Biomedical Research-製薬・医療分野:企業M&A・提携分析
    Summary Whitehead Institute for Biomedical Research (Whitehead Institute), a subsidiary of Massachusetts Institute of Technology is a non-profit research and educational institute that offers technologies to improve human health. The institute undertakes the development of therapies for diseases tha …
  • Byco Petroleum Pakistan Ltd (BYCO):企業の財務・戦略的SWOT分析
    Byco Petroleum Pakistan Ltd (BYCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Arise AB (ARISE):企業の財務・戦略的SWOT分析
    Arise AB (ARISE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Silver Peak Systems Inc:企業の戦略的SWOT分析
    Silver Peak Systems Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Koninklijke Wessanen N.V.:企業の戦略・SWOT・財務情報
    Koninklijke Wessanen N.V. - Strategy, SWOT and Corporate Finance Report Summary Koninklijke Wessanen N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Azelis Holding S.A.:企業の戦略・SWOT・財務情報
    Azelis Holding S.A. - Strategy, SWOT and Corporate Finance Report Summary Azelis Holding S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Glory Ltd
    Glory Ltd - Strategy, SWOT and Corporate Finance Report Summary Glory Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • NH Foods Ltd.:企業の戦略・SWOT・財務情報
    NH Foods Ltd. - Strategy, SWOT and Corporate Finance Report Summary NH Foods Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Croma-Pharma GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Croma-Pharma GmbH (Croma Pharma) is a pharmaceutical company which focuses on the development and commercialization of drugs in the field of aesthetic dermatology. It offers princess injectables, princess skincare, and princess lift products. The company’s princess skincare products comprise …
  • Anheuser-Busch InBev SA/NV:企業の戦略・SWOT・財務情報
    Anheuser-Busch InBev SA/NV - Strategy, SWOT and Corporate Finance Report Summary Anheuser-Busch InBev SA/NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Cimentos de Portugal SGPS SA:企業の戦略的SWOT分析
    Cimentos de Portugal SGPS SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • QEP Resources Inc (QEP):企業の財務・戦略的SWOT分析
    QEP Resources Inc (QEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆